π©Ί CPT 55840 - Prostatectomy, Retropubic Radical, With or Without Nerve Sparing
π Code Description
Full Official Description: Prostatectomy, retropubic radical, with or without nerve sparing
CPT 55840 describes an open retropubic radical prostatectomy (RRP), the historically foundational surgical treatment for clinically localized prostate cancer. This is the traditional open surgical approach, distinct from the laparoscopic and robotic approaches described under 55866. The procedure was largely standardized by Dr. Patrick Walsh at Johns Hopkins in the 1980s, whose anatomic nerve-sparing technique revolutionized outcomes and is the reason the procedure is also eponymously referred to as the Walsh radical prostatectomy.
The procedure is performed through a lower midline extraperitoneal incision (suprapubic, infraumbilical) or occasionally a Pfannenstiel incision and involves:
- Extraperitoneal development of the space of Retzius (retropubic space)
- Endopelvic fascia incision and development of the lateral prostatic fascia plane
- Ligation and division of the dorsal venous complex (DVC) β the Santorini plexus β to achieve hemostasis at the apex
- Bladder neck dissection with careful preservation of the posterior bladder neck when possible
- Seminal vesicle and vas deferens dissection and excision, dissecting posterior to the prostate
- Neurovascular bundle (NVB) dissection β the hallmark of nerve-sparing technique β with interfascial, intrafascial, or extrafascial dissection depending on oncologic margin risk and surgeon preference; may be unilateral or bilateral depending on tumor laterality and staging
- Apical dissection with precise urethral transection to maximize functional urethral length
- En bloc removal of the prostate gland with attached seminal vesicles
- Vesicourethral anastomosis β typically performed with interrupted or running absorbable suture (Van Velthoven technique or equivalent)
- Pelvic drain placement and wound closure in layers
Caution
β οΈ Critical Coding Distinction: The descriptor states βwith or without nerve sparingβ β meaning 55840 is reported regardless of whether nerve sparing is performed on one side, both sides, or not at all. There is no separate, higher-valued code for nerve-sparing open RP. Nerve sparing status affects clinical documentation and outcomes reporting but does not change the CPT code selection.
β οΈ Approach Distinction: 55840 is exclusively for the open retropubic approach. If the surgery is performed laparoscopically or with robotic assistance, 55866 must be used instead. If the approach is perineal (not retropubic), 55810, 55812, or 55815 apply. Never use 55840 for a robotic or laparoscopic case.
π° Work RVUs & Payment
| Component | Value |
|---|---|
| wRVU (Facility) | 26.97 |
| wRVU (Non-Facility) | 26.97 |
| Global Period | 090 (ninety days) |
| Assistant Payable | β Yes (indicator: 1) |
| Co-Surgery | β Yes (indicator: 1) |
| Team Surgery | β No (indicator: 0) |
| Bilateral Surgery | N/A β midline organ |
| Multiple Procedure Indicator | 2 (standard reduction applies) |
| Endoscopic Base Code | N/A |
| Robotic Platform | β Not applicable; open approach |
wRVU Note: The wRVU for 55840 (26.97) is notably lower than 55866 (34.25), despite being a comparable oncologic procedure. This differential reflects the AMA RUCβs valuation of the additional technical skill, equipment complexity, and procedural duration typically associated with robotic/laparoscopic approaches. However, open radical prostatectomy remains a highly complex procedure with significant surgical skill requirements, and this differential is a subject of ongoing discussion in the urology community.
90-Day Global Period: All standard postoperative care β including office visits, catheter management, and routine complication management β is bundled for 90 days following the procedure date. Services separately billable within the global period include unrelated E/M encounters (-24), staged procedures (-58), unplanned return to the OR (-78), and care by a different physician (-54/-55).
Assistant at Surgery: 55840 carries an assistant surgeon payable indicator of 1, confirming Medicare and most commercial payers will reimburse an assistant surgeon. This is standard for major open pelvic oncologic surgery. The assistant is billed using modifier -80, -81, or -AS on a duplicate line.
β Whatβs Included (Bundled into 55840)
The following services are not separately reportable when performed as integral components of 55840:
- Lower midline or Pfannenstiel incision and fascial dissection
- Development of the retropubic/Space of Retzius
- Endopelvic fascia incision bilaterally
- Dorsal venous complex (DVC/Santorini plexus) suture ligation and division
- Bladder neck dissection and preservation (anterior and posterior)
- Seminal vesicle dissection and excision β bilateral
- Vas deferens ligation and excision β bilateral
- Neurovascular bundle dissection β unilateral or bilateral (with or without nerve sparing; both are inclusive)
- Apical dissection and urethral transection
- Posterior urethral reconstruction (Rocco stitch) when performed
- Vesicourethral anastomosis β all suture techniques
- Pelvic drain placement (Jackson-Pratt or Blake drain)
- Foley catheter placement and balloon inflation
- Wound closure (fascial, subcutaneous, skin)
- Specimen labeling, inking, and submission to pathology
- Standard intraoperative blood loss management and transfusion oversight
π« Excludes / Separately Reportable
| Service | Separately Reportable Code | Notes |
|---|---|---|
| Bilateral pelvic lymphadenectomy (extended, full) | 38500, 38770 | See detailed section below; open PLND codes |
| Limited pelvic lymph node sampling/biopsy | 38562 | Fewer nodes; sentinel or targeted sampling |
| Cystourethroscopy at same session (separate indication) | 52000 | Append modifier -59 or -XU; must be distinct |
| Transurethral resection of bladder neck contracture | 52640 | Staged procedure; append 58 if within global |
| Urethral dilation at same session (separate, unrelated) | 53600-53665 | Only if clearly distinct from prostatectomy |
| Placement of penile prosthesis (staged) | 54400, 54405 | Staged; append modifier -58 |
| Postoperative complication requiring return to OR | Appropriate surgical code + -78 | Within 90-day global period |
| Unrelated E/M during global period | Appropriate E/M + -24 | Must document unrelated condition |
| Staged procedure within global | Appropriate CPT + -58 | Pre-planned; documented in operative report |
| Conversion from laparoscopic/robotic to open (mid-case) | Bill 55840; append -53 to 55866 if robotic was attempted | Document conversion reason thoroughly |
| Anesthesia (general or regional) | Billed by anesthesia provider per anesthesia guidelines | Not surgeon-billable unless personally administered |
| Surgical pathology β radical prostatectomy specimen | 88309 - Level VI Surgical Pathology | Pathologist bills separately |
| Intraoperative frozen section | 88331, 88332 | Pathologist bills separately; common for margins |
π΄ Open Pelvic Lymph Node Dissection β Critical Add-On Distinction
β οΈ This is the most important billing nuance for 55840. Unlike 55845 (which bundles full bilateral pelvic PLND into the open RP code), 55840 does NOT include lymph node dissection. When open PLND is performed at the same session, it must be reported separately.
| CPT | Description | When to Use with 55840 |
|---|---|---|
| 38770 | Pelvic lymphadenectomy, including external iliac, hypogastric, and obturator nodes | Standard open bilateral pelvic lymphadenectomy performed at same session |
| 38562 | Limited pelvic and para-aortic lymph node sampling, open | Sentinel node or limited sampling only; not full PLND |
| 38500 | Biopsy or excision of lymph node(s); open, superficial | Limited lymph node biopsy, superficial only; rarely applicable |
| 38571 | Laparoscopic bilateral pelvic lymphadenectomy | β Do NOT use with 55840 β 38571 is laparoscopic; approach mismatch |
| 38572 | Laparoscopic bilateral PLND with peritoneal evaluation | β Do NOT use with 55840 β laparoscopic code |
β Vs. 55845: If the surgeon performs an open retropubic RP with full bilateral PLND in a single session and wants a single code, 55845 is an alternative that bundles them. However, separate billing of 55840 + 38770 may yield a higher combined reimbursement in some payer contracts. Always verify your payerβs fee schedule. When using 55845, do NOT additionally bill 38770 β it is already bundled.
πΏ Code Tree / Family
Male Genital System - Prostate - Radical Prostatectomy (55800-55866)
β
βββ 55801 Prostatectomy; perineal, subtotal (including nerve-sparing)
β βββ Subtotal (not radical); rarely performed
β
βββ ββ PERINEAL RADICAL PROSTATECTOMY ββββββββββββββββββββββββββββββββββ
β
βββ 55810 Prostatectomy; radical perineal
β βββ Perineal approach; no nerve sparing; no PLND
β
βββ 55812 Prostatectomy; radical perineal, with lymph node biopsy(s)
β βββ Perineal approach + limited node sampling
β
βββ 55815 Prostatectomy; radical perineal, with bilateral pelvic
β lymphadenectomy, incl. external iliac, hypogastric,
β and obturator nodes
β βββ Perineal approach + full PLND bundled
β
βββ ββ RETROPUBIC RADICAL PROSTATECTOMY ββββββββββββββββββββββββββββββββ
β
βββ 55840 β YOU ARE HERE
β Prostatectomy; retropubic radical, with or without
β nerve sparing
β βββ Open retropubic; no PLND included
β βββ Add: 38770 - Open bilateral pelvic PLND
β βββ Add: 38562 - Limited lymph node sampling
β
βββ 55842 Prostatectomy; retropubic radical, with lymph node biopsy(s)
β βββ Open retropubic + limited/sentinel node biopsy bundled
β
βββ 55845 Prostatectomy; retropubic radical, with bilateral pelvic
β lymphadenectomy, incl. external iliac, hypogastric,
β and obturator nodes
β βββ Open retropubic + FULL bilateral PLND bundled
β
βββ ββ LAPAROSCOPIC / ROBOTIC βββββββββββββββββββββββββββββββββββββββββββ
β
βββ 55866 Laparoscopy, surgical prostatectomy, radical, retropubic,
including nerve sparing; includes robotic assistance
when performed
βββ Laparoscopic/robotic; PLND NOT bundled
βββ Add: 38571 - Laparoscopic bilateral pelvic PLND
βββ Add: 38572 - Laparoscopic PLND + peritoneal eval
π Open Retropubic Approach Comparison Table
| CPT Code | Nerve Sparing? | PLND Included? | Notes |
|---|---|---|---|
| 55840 | β With or without | β No | Report 38770 separately for PLND |
| 55842 | β With or without | Limited only (biopsy) | Node biopsy bundled; not full PLND |
| 55845 | β With or without | β Full bilateral PLND bundled | Single code for RP + PLND |
π₯ ICD-10-CM Commonly Paired Diagnoses
π΄ Primary Indication β Prostate Cancer
| ICD-10-CM | Description | HCC | Notes |
|---|---|---|---|
| C61 | Malignant neoplasm of prostate | β HCC 12 | Overwhelmingly the primary indication for 55840; required for medical necessity |
C61 is the definitive primary diagnosis for radical prostatectomy. This procedure is curative-intent oncologic surgery. Any other primary diagnosis for 55840 is exceedingly rare and would require strong clinical justification.
π΄ Staging / Risk Context Diagnoses (Secondary)
| ICD-10-CM | Description | HCC | Notes |
|---|---|---|---|
| Z80.42 | Family history of malignant neoplasm of prostate | β No HCC | Supplemental risk documentation |
| Z85.46 | Personal history of malignant neoplasm of prostate | β No HCC | β Do NOT use during active treatment admission; applies only post-treatment at follow-up |
| R97.21 | Rising PSA following treatment for malignant neoplasm of prostate | β No HCC | Applicable if salvage RP after prior radiation; PSA recurrence |
π΄ Lymph Node Pathology (If PLND Performed Concurrently)
| ICD-10-CM | Description | HCC | Notes |
|---|---|---|---|
| C77.5 | Secondary and unspecified malignant neoplasm of intrapelvic lymph nodes | β HCC 8 | Confirmed pelvic LN metastases on PLND; extremely high RAF impact; code when pathology confirms |
| D36.0 | Benign neoplasm of lymph nodes | β No HCC | Rare; benign reactive nodes |
| D48.7 | Neoplasm of uncertain behavior of other specified sites | β No HCC | Atypical nodes without confirmed malignancy |
π΄ Perioperative and Postoperative Diagnoses
| ICD-10-CM | Description | HCC | Notes |
|---|---|---|---|
| N99.510 | Cystostomy hemorrhage | β No HCC | Post-op anastomotic hemorrhage |
| T81.32XA | Disruption of internal operation wound, NEC, initial encounter | β No HCC | Anastomotic leak; vesicourethral disruption |
| N35.812 | Other urethral stricture, male, membranous urethra | β No HCC | Vesicourethral anastomotic stricture (late complication) |
| N39.3 | Stress incontinence (male) | β No HCC | Post-prostatectomy urinary incontinence |
| N39.41 | Urge incontinence | β No HCC | Post-op overactive bladder |
| N52.01 | Erectile dysfunction due to arterial insufficiency | β No HCC | Post-RP ED; vascular mechanism |
| N52.02 | Corporo-venous occlusive erectile dysfunction | β No HCC | Post-RP ED; venogenic |
| N52.03 | Combined arterial insufficiency and corporo-venous occlusive ED | β No HCC | Most common post-RP ED mechanism |
| N52.9 | Male erectile dysfunction, unspecified | β No HCC | Use only if etiology undocumented |
| R33.9 | Retention of urine, unspecified | β No HCC | Post-catheter removal retention |
| N13.8 | Other obstructive and reflux uropathy | β No HCC | Post-op obstruction/stricture |
| D62 | Acute posthemorrhagic anemia | β No HCC | Significant intraoperative blood loss requiring transfusion |
| Z79.01 | Long-term (current) use of anticoagulants | β No HCC | Documents perioperative anticoagulation management |
π΄ Common Comorbidities (CCs/MCCs) β Inpatient DRG Impact
| ICD-10-CM | Description | HCC | CC/MCC Status | Notes |
|---|---|---|---|---|
| C77.5 | Secondary malignant neoplasm, intrapelvic lymph nodes | β HCC 8 | MCC | Positive PLND nodes β highest DRG impact |
| N17.9 | Acute kidney injury, unspecified | β No HCC | MCC | Post-op AKI from blood loss, contrast, or obstruction |
| J96.00 | Acute respiratory failure, unspecified | β No HCC | MCC | Post-op respiratory complications |
| I48.0 | Paroxysmal atrial fibrillation | β No HCC | CC | New-onset perioperative A-fib |
| E11.65 | Type 2 DM with hyperglycemia | β No HCC | CC | Perioperative glucose management |
| I10 | Essential (primary) hypertension | β No HCC | CC | Perioperative hypertensive episodes |
| J44.1 | COPD with acute exacerbation | β No HCC | MCC | Post-op pulmonary decompensation |
| Z96.641 | Presence of right artificial hip joint | β No HCC | β | Documents surgical positioning challenges |
| E66.01 | Morbid obesity due to excess calories | β No HCC | CC | Increased surgical complexity; supports -22 |
| D62 | Acute posthemorrhagic anemia | β No HCC | CC | Intraoperative blood loss with transfusion |
π‘ HCC Details
C61 - Malignant Neoplasm of Prostate β HCC 12
| Field | Detail |
|---|---|
| HCC Category | HCC 12 β Prostate, Testicular, and Other Male Genital Cancers |
| CMS-HCC Model | Version 28 (current) |
| RAF Score (Community, Non-Dual) | ~0.149 |
| Clinical Significance | Designates the patient as a high-complexity beneficiary in risk-adjusted payment models including Medicare Advantage, ACO REACH, and MSSP |
| Active vs. Historical | Must be documented as actively treated cancer during the admission β the radical prostatectomy itself constitutes active treatment |
| Post-Surgery Transition | After prostatectomy with confirmed clear margins and no residual disease: transition to Z85.46 (personal history) once oncologist formally documents NED (no evidence of disease) at appropriate follow-up |
| PSA Recurrence Post-RP | If biochemical recurrence (BCR) occurs: R97.21 (rising PSA after treatment) with C61 if clinical recurrence is confirmed by imaging or biopsy |
| Coding Clinic Guidance | C61 may be coded throughout the entire course of active surveillance, treatment, and adjuvant therapy β the cancer is βactiveβ until formally documented as resolved or in remission |
C77.5 - Secondary Malignant Neoplasm, Intrapelvic Lymph Nodes β HCC 8
| Field | Detail |
|---|---|
| HCC Category | HCC 8 β Metastatic Cancer and Acute Leukemia |
| CMS-HCC Model | Version 28 |
| RAF Score (Community, Non-Dual) | ~2.659 β one of the highest RAF scores in the HCC model |
| Clinical Significance | Node-positive prostate cancer (pN1 disease) radically changes the patientβs risk profile and expected cost of care |
| When to Code | Only when pathology confirms lymph node metastases β either intraoperative frozen section or final surgical pathology; do not code based on clinical suspicion alone |
| Code Pairing | Always assign C61 (primary site) + C77.5 (secondary/metastatic site) together β never code C77.5 without C61 in this context |
| MS-DRG Impact | C77.5 typically functions as an MCC β moves the case from DRG 716 or 717 β DRG 715 with significantly higher relative weight and reimbursement |
| Documentation Requirement | Inpatient coders: if final pathology returns after discharge, the results may be added to the discharge record per facility policy; query the attending if pathology is noted in the chart but not documented in the discharge summary |
π§ Applicable Modifiers
| Modifier | Description | Application to 55840 |
|---|---|---|
| -80 | Assistant Surgeon | MD/DO primary assistant; reimbursed ~16% of primary surgeon allowable |
| -81 | Minimum Assistant Surgeon | Second assistant with limited role; less common for open major pelvic surgery |
| -AS | PA/NP/CNS as Assistant at Surgery | Non-physician assistant; ~85% of the assistant allowable (β13.6% of primary) |
| -62 | Two Surgeons | Two surgeons of different specialties performing distinct parts simultaneously; e.g., urologic oncologist + colorectal surgeon for combined pelvic resection |
| -22 | Increased Procedural Services | Exceptional complexity: prior pelvic radiation (salvage RP), prior TURP with scarring, morbid obesity, prior pelvic surgery with extensive adhesions, pelvic fracture history; requires detailed operative note documentation + cover letter |
| -52 | Reduced Services | Procedure substantially less than described β e.g., vesicourethral anastomosis not completed due to tissue deficiency; rare |
| -53 | Discontinued Procedure | Procedure halted due to unanticipated medical emergency (e.g., intraoperative cardiac event, uncontrollable hemorrhage) |
| -54 | Surgical Care Only | Performing surgeon provides only intraoperative care; another provider will assume postoperative care (e.g., patient transferred to another institution) |
| -55 | Postoperative Management Only | Receiving provider assumes postoperative global period care from the operating surgeon |
| -56 | Preoperative Management Only | Rarely applicable; surgeon provides only preoperative workup |
| -58 | Staged Procedure | Subsequent related procedure planned and documented as staged within 90-day global (e.g., penile prosthesis, sling for post-RP incontinence) |
| -78 | Unplanned Return to OR | Return for complication during global period (anastomotic leak, pelvic hematoma, wound dehiscence) |
| -79 | Unrelated Procedure During Global | Completely unrelated surgery within 90-day global (e.g., appendectomy, hernia repair for unrelated condition) |
| -24 | Unrelated E/M During Global | Office visit for unrelated condition during global; must document unrelated diagnosis |
| -32 | Mandated Service | Workersβ comp, employer-required, or other mandated service |
| -47 | Anesthesia by Surgeon | Surgeon personally administers regional or general anesthesia; extremely rare |
| -LT / -RT | Left/Right Side | Not applicable to prostate (midline organ); may appear on nerve sparing documentation for laterality clarity but does not change code |
π¨ MS-DRG (Inpatient)
55840 is a major open surgical procedure that virtually always results in inpatient admission. Unlike laparoscopic/robotic approaches that may be performed in 23-hour observation status, open radical prostatectomy typically requires a 2-4 day inpatient stay due to greater blood loss, longer anesthetic duration, and the associated recovery from a lower midline laparotomy incision.
For inpatient admissions, the ICD-10-PCS procedure code is reported on the UB-04 claim form in lieu of CPT.
ICD-10-PCS Equivalents
| ICD-10-PCS | Description | Notes |
|---|---|---|
0VT00ZZ | Resection of Prostate, Open | Primary PCS code for open radical prostatectomy |
0VT0XZZ | Resection of Prostate, External | Rarely applicable; do not confuse with open |
07B70ZZ | Excision of Left Inguinal Lymphatic, Open | If extended lymph dissection includes inguinal |
07BC0ZZ | Excision of Pelvic Lymphatic, Open, No Qualifier | Open pelvic lymphadenectomy β therapeutic |
07BC0ZX | Excision of Pelvic Lymphatic, Open, Diagnostic | Open pelvic lymph node sampling β diagnostic/biopsy |
PCS Root Operation β Radical Prostatectomy: Resection (T) β cutting out or off, without replacement, all of a body part. Because the entire prostate gland is removed in a radical prostatectomy, Resection is correct, not Excision (B), which denotes partial removal only. This is a frequently tested distinction in inpatient coding audits.
PCS 4th Character β Approach:
0= Open. For 55840, this is always0(Open). A laparoscopic or robotic approach would use4(Percutaneous Endoscopic) and maps to 55866, not 55840.
PCS Root Operation β Open PLND: Excision (B) with:
- 7th Character
Z(No Qualifier) = therapeutic/staging lymphadenectomy- 7th Character
X(Diagnostic) = biopsy/sampling only Apply body part character appropriate to the nodal region dissected.
MS-DRG Assignment
| MS-DRG | Description | Type | Typical Scenario |
|---|---|---|---|
| 715 | Other Male Reproductive System O.R. Procedures for Malignancy with MCC | Surgical | C61 + MCC (e.g., C77.5, N17.9, J96.00) |
| 716 | Other Male Reproductive System O.R. Procedures for Malignancy with CC | Surgical | C61 + CC (e.g., E11.65, I10, D62, E66.01) |
| 717 | Other Male Reproductive System O.R. Procedures for Malignancy without CC/MCC | Surgical | C61, no significant coded comorbidities |
| 729 | Other Male Reproductive System O.R. Procedures with MCC | Surgical | Non-malignancy principal dx + MCC (uncommon for RP) |
| 730 | Other Male Reproductive System O.R. Procedures with CC | Surgical | Non-malignancy principal dx + CC |
| 731 | Other Male Reproductive System O.R. Procedures without CC/MCC | Surgical | Non-malignancy, no comorbidities |
DRG Relative Weights (Approximate β FY2025)
| MS-DRG | Relative Weight | Geometric Mean LOS | Arithmetic Mean LOS |
|---|---|---|---|
| 715 | ~4.20 | ~6.5 days | ~8.1 days |
| 716 | ~2.38 | ~3.8 days | ~4.7 days |
| 717 | ~1.52 | ~2.1 days | ~2.6 days |
| 729 | ~4.08 | ~6.1 days | ~7.8 days |
| 730 | ~2.31 | ~3.5 days | ~4.4 days |
| 731 | ~1.41 | ~1.9 days | ~2.3 days |
π₯ Inpatient Coder Note β MS-DRG Optimization for 55840:
Open radical prostatectomy cases are among the highest-value urologic surgical DRGs β but only when CCs and MCCs are accurately documented and coded. Key optimization strategies:
- C77.5 = MCC in nearly all grouper versions β always review the PLND pathology report for lymph node metastasis; if confirmed and documented by the attending, code it; this single code can shift a 717 β 715 and add substantial reimbursement
- D62 (acute posthemorrhagic anemia) is a CC β document when estimated blood loss (EBL) is significant and transfusion is given; query surgeon if transfusion is noted in anesthesia records but not mentioned in the operative note
- N17.9 (acute kidney injury) is an MCC β review post-op creatinine trends; if AKI is documented by the treatment team, it should be coded; query if borderline
- Perioperative DVT/PE (I82.401, I26.09) β both are MCCs; always review post-op Doppler and CT-PA results
- Blood transfusion β document the reason for transfusion in the operative or post-op note (blood loss, pre-op anemia, intraoperative hemodynamic instability) to support D62 or related codes
- Open RP patients are typically older with more comorbidities than robotic patients β thoroughly review the H&P, nursing notes, and consultant notes for documented conditions managed during the stay
π Coding Examples
π’ Example 1 - Standard Open Retropubic RP, Bilateral Nerve Sparing, No PLND
Clinical Scenario: A 61-year-old male with Gleason 7 (3+4), clinical T2aN0M0, PSA 6.8 ng/mL undergoes open retropubic radical prostatectomy with bilateral nerve sparing. No pelvic lymph node dissection performed per low-risk nomogram (Briganti <5%). EBL 450 mL. No transfusion. Foley placed, JP drain placed. Final pathology: pT2c pNx Gleason 3+4, negative margins, seminal vesicles negative.
CPT Codes (Professional/Outpatient):
- 55840 - Open retropubic radical prostatectomy with or without nerve sparing
ICD-10-CM:
- C61 - Malignant neoplasm of prostate
Inpatient UB-04 (ICD-10-PCS):
MS-DRG: 717 (no CCs/MCCs coded) β consider querying for comorbidities managed during stay
π’ Example 2 - Open Retropubic RP WITH Bilateral Pelvic Lymphadenectomy (Separately Billed)
Clinical Scenario: A 66-year-old male with Gleason 4+4=8 (Grade Group 4), clinical T3aN0M0, PSA 22.4. High-risk disease per NCCN criteria. Open retropubic radical prostatectomy performed. Bilateral extended pelvic lymph node dissection performed removing external iliac, obturator fossa, and hypogastric (internal iliac) nodal packets bilaterally β 22 nodes total. Final pathology: pT3a, Gleason 4+4, right margin positive, 3/22 pelvic lymph nodes positive for metastatic adenocarcinoma. Postoperative Hgb 7.8 g/dL; two units pRBC transfused.
CPT Codes:
- 55840 - Open retropubic radical prostatectomy with or without nerve sparing
- 38770 - Pelvic lymphadenectomy, including external iliac, hypogastric, and obturator nodes (separately reportable; NOT bundled in 55840)
ICD-10-CM:
- C61 - Malignant neoplasm of prostate (principal)
- C77.5 - Secondary malignant neoplasm, intrapelvic lymph nodes β MCC; confirmed on path
- D62 - Acute posthemorrhagic anemia β CC; transfusion administered
Inpatient UB-04 (ICD-10-PCS):
- Principal Dx: C61
- Secondary Dx: C77.5 (MCC), D62 (CC)
- Procedures:
0VT00ZZ- Resection of Prostate, Open07BC0ZZ- Excision of Pelvic Lymphatic, Open
MS-DRG: 715 β driven by C77.5 as MCC; highest-weight DRG in this family
π‘ Coder Impact: The combination of C61 + C77.5 + D62 on this claim maximizes DRG weight. Failing to code C77.5 (often returned on final path after discharge) would drop this case to DRG 716 or 717 β a significant reimbursement difference. Confirm your facilityβs policy on late pathology result coding and issue a physician query if the discharge summary does not mention the positive nodes.
π’ Example 3 - Open RP as Salvage After Prior Radiation, Modifier 22
Clinical Scenario: A 69-year-old male with rising PSA (R97.21) after prior external beam radiation therapy (EBRT) for C61 three years ago. Biochemical recurrence confirmed; salvage open retropubic radical prostatectomy planned. Operative note documents: βExtensive radiation fibrosis of periprostatic tissues, complete obliteration of normal fascial planes, adherence of posterior bladder wall to prostate, dense peri-rectal fibrosis requiring careful sharp dissection to avoid rectal injury. Total operative time 5 hours 40 minutes, significantly greater than standard radical prostatectomy.β
CPT Codes:
- 55840 - -22 - Open retropubic radical prostatectomy, increased procedural services (Submit with cover letter detailing operative complexity and increased time/difficulty)
ICD-10-CM:
- C61 - Malignant neoplasm of prostate (active recurrence)
- R97.21 - Rising PSA following treatment (supplemental; documents clinical context)
- Z85.46 - β Do NOT use β C61 is active; personal history code is inappropriate
Inpatient UB-04 (ICD-10-PCS):
- Principal Dx: C61
- Procedure:
0VT00ZZ- Resection of Prostate, Open
MS-DRG: 716 or 715 depending on comorbidities coded; salvage RP patients often have more comorbidities supporting CCs/MCCs
π‘ Modifier -22 Guidance: CMS does not have a specific claims processing instruction for -22 β it is manually reviewed. Expect an initial denial or RTP (return to provider); resubmit with an itemized cover letter describing the specific factors that increased difficulty. A 10-30% additional payment may be approved on appeal. Always document in the operative report before billing: βThis procedure was significantly more difficult and time-consuming than a standard radical prostatectomy due to [specific reasons].β
π’ Example 4 - Open RP Converted From Robotic (Mid-Procedure Conversion)
Clinical Scenario: A 64-year-old male scheduled for RARP. Robotic system is docked; initial dissection begins. Intraoperative finding of dense adhesions from prior sigmoid colectomy makes laparoscopic exposure unsafe; decision made to convert to open approach. Robotic instruments removed, Pfannenstiel incision extended to standard lower midline; open retropubic radical prostatectomy completed. Total case time 4 hours 10 minutes.
CPT Codes:
- 55866 - -53 - Laparoscopic/robotic prostatectomy, discontinued (robotic portion started but not completed)
- 55840 - Open retropubic radical prostatectomy (the completed procedure) (Append -22 to 55840 if operative note supports increased complexity due to conversion circumstances)
ICD-10-CM:
- C61 - Malignant neoplasm of prostate
- Z87.39 - Personal history of other diseases of the digestive system (prior colectomy; documents surgical complexity)
β οΈ Coding Alert: Reporting both 55866--53 and 55840 for a conversion case is not universally accepted by all payers. Some payers will only reimburse 55840 for the completed procedure and will deny 55866--53. Review individual payer policies. The operative note must clearly document that the laparoscopic/robotic approach was genuinely initiated (not merely attempted portsite insufflation) to justify 55866--53.
π’ Example 5 - Unplanned Return to OR Within Global Period (Pelvic Hematoma)
Clinical Scenario: Patient underwent open RP (55840) on Day 1. Discharged POD3. Readmitted POD7 with expanding pelvic hematoma on CT scan. Return to OR for open exploration, hematoma evacuation, and hemostasis.
CPT Codes (Return to OR Encounter):
- 49000 - Exploratory laparotomy (or appropriate pelvic exploration/hemostasis code) + -78 - Unplanned return to OR during global period
ICD-10-CM (Readmission):
- Principal Dx: N99.820 - Postprocedural hemorrhage of genitourinary system organ following procedure (or T81.810XD - hematoma complicating procedure, depending on specificity documented)
- Secondary Dx: C61 - Underlying malignancy (reason for original procedure)
π‘ Inpatient Coder Note:
The readmission for a complication is a separate encounter. The complication code (postprocedural hemorrhage/hematoma) becomes the principal diagnosis for the second admission. C61 is coded as secondary. The global period of 55840 continues to run from the original surgery date β the return-to-OR procedure within this window requires modifier -78 on the professional claim.
π’ Example 6 - Assistant Surgeon Billing (Open RP)
Clinical Scenario: Urologic oncology fellow serves as primary assistant during open RP. Attending operates as primary surgeon.
Primary Surgeon CPT:
- 55840 - Open retropubic radical prostatectomy
Assistant Surgeon CPT:
ICD-10-CM (both claims):
- C61 - Malignant neoplasm of prostate
Payment: Medicare reimburses modifier -80 at 16% of the primary surgeonβs allowed amount. Teaching hospital exception: in a teaching setting, the assistant may not be separately billable if a resident is performing the assistance; verify teaching physician rules.
β οΈ Common Coding Pitfalls
- β Do not use 55840 for a laparoscopic or robotic prostatectomy β even if the surgeon documents a βretropubic approach,β the presence of laparoscopic ports or robotic arms mandates 55866
- β Do not assume PLND is included in 55840 β unlike 55845, this code explicitly excludes lymphadenectomy; failure to separately bill 38770 when PLND was performed results in significant revenue leakage
- β Do not report 55840 + 55845 together β they are mutually exclusive; 55845 already bundles the open RP + PLND; choose one based on documentation and fee schedule analysis
- β Do not code Z85.46 (personal history of prostate cancer) during the same inpatient admission as 55840 β the cancer is actively being treated; C61 is the appropriate active malignancy code
- β Do not miss C77.5 on the inpatient claim when PLND pathology confirms positive nodes β this is an MCC with enormous DRG and risk-adjustment impact
- β Do not code C77.5 based solely on clinical suspicion or intraoperative appearance β pathologic confirmation is required
- β Always review the final surgical pathology report for margin status, lymph node counts, and extraprostatic extension β these findings drive secondary diagnoses and DRG optimization
- β Always check the anesthesia record for EBL and transfusion β significant blood loss with transfusion supports D62 (acute posthemorrhagic anemia, CC) which may shift DRG tier
- β Modifier -22 must be supported by operative note language specifically documenting the factors creating unusual difficulty β do not append -22 without this documentation
- β The 90-day global period begins the day after surgery (or day of for same-day procedures) β track carefully to determine whether subsequent encounters require global-period modifiers or can be billed independently
- β
For inpatient PCS coding: confirm the approach character β open =
0; percutaneous endoscopic (laparoscopic/robotic) =4; these map to different CPT codes and must not be mixed
π Quick Reference Summary
| Field | Value |
|---|---|
| Code | 55840 |
| Type | CPT - Major Open Surgery |
| System | Male Genital |
| Body Part | Prostate (entire) |
| Approach | Open Retropubic |
| Nerve Sparing | β Inclusive (with or without) |
| PLND Inclusive | β No β bill 38770 separately |
| Robotic Inclusive | β No β use 55866 for robotic |
| Global Period | 090 (90 days) |
| wRVU (Fac/Non-Fac) | 26.97 |
| Assistant Payable | β Yes β -80, -81, -AS |
| Co-Surgery | β Yes β -62 |
| Modifier -22 Eligible | β Yes β with documentation |
| PCS Equivalent | 0VT00ZZ |
| PCS Root Operation | Resection (T) β entire organ |
| Primary DX | C61 β HCC 12 |
| Node Met DX | C77.5 β HCC 8 (MCC) |
| MS-DRG (Malignancy) | 715 / 716 / 717 |
| MS-DRG (Non-Malig) | 729 / 730 / 731 |
| Open PLND Add-On | 38770 (separately reportable) |
| vs. 55845 | 55845 bundles full PLND; 55840 does not |
| vs. 55866 | 55866 = laparoscopic/robotic; 55840 = open only |
AMA CPT Professional Edition 2024 Β· CMS Physician Fee Schedule Look-Up Tool FY2025 Β· CMS-HCC Risk Adjustment Model v28 Β· CMS NCCI Policy Manual for Medicare Services v30 Β· AHA Coding Clinic for ICD-10-CM/PCS Β· CMS ICD-10-PCS Official Guidelines for Coding and Reporting FY2025 Β· CMS MS-DRG Grouper v41 Β· CMS IPPS Final Rule FY2025 Β· NCCN Clinical Practice Guidelines in Oncology - Prostate Cancer v2.2025
Crystal's MCW Coder Hub